HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

isoindigotin

used in treatment of chronic granulocytic leukemia; structure given in first source

Also Known As:

isoindigo; 2H-Indol-2-one, 3-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)-1,3-dihydro-, (3E)-

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - isoindigotin: 6

Experts

1.	Bogdanov, Andrei V: 1 article (01/2021)
2.	Mironov, Vladimir F: 1 article (01/2021)
3.	Ashizawa, Minoru: 1 article (01/2020)
4.	Cheng, Ji-Xin: 1 article (01/2020)
5.	Hasegawa, Tsukasa: 1 article (01/2020)
6.	Huang, Kai-Chih: 1 article (01/2020)
7.	Lee, Hyeon Jeong: 1 article (01/2020)
8.	Lin, Peng: 1 article (01/2020)
9.	Luo, Xuyi: 1 article (01/2020)
10.	Mei, Jianguo: 1 article (01/2020)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2021 - "The potentials of the use of polymer structures based on isoindigo as photoactive component in the photoelectrochemical reduction of water, as matrix for MALDI spectrometry and in photothermal cancer therapy are also shown. " 08/03/2016 - "A Donor-Acceptor Conjugated Polymer with Alternating Isoindigo Derivative and Bithiophene Units for Near-Infrared Modulated Cancer Thermo-Chemotherapy."
2.	Chagas Disease (American Trypanosomiasis) 11/01/2011 - "The biological activities of diversely substituted glycosyl-isoindigo derivatives against the causative agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis) are reported. " 11/01/2011 - "Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis)."
3.	African Trypanosomiasis (Nagana) 11/01/2011 - "The biological activities of diversely substituted glycosyl-isoindigo derivatives against the causative agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis) are reported. " 11/01/2011 - "Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis)."
4.	Prostatic Neoplasms (Prostate Cancer) 01/01/2020 - "Here, 2-[3-(1,3-dicarboxypropyl) ureido] pentanedioic acid (DUPA)-conjugated ligand and bis-isoindigo-based polymer (BTII) are synthesized to formulate semiconducting polymer nanoparticles (BTII-DUPA SPN) as a prostate-specific membrane antigen (PSMA)-targeted probe for prostate cancer imaging in the NIR-II window. "
5.	Malaria 11/01/2011 - "The biological activities of diversely substituted glycosyl-isoindigo derivatives against the causative agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis) are reported. " 11/01/2011 - "Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis)."

Related Drugs and Biologics

1.	Polymers
2.	Ligands
3.	Antigens
4.	Acids

Related Therapies and Procedures

1.	Therapeutics
2.	Drug Therapy (Chemotherapy)